AVLN

Conviction 100HealthcareScan · Mon, Aug 10, 2026

AVLN$34.43+1.50%

ResistanceSupportVol 14Insider buy

Vol MA14 216.96K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Avalyn Pharma Inc.Biotechnologywww.avalynpharma.com ↗

Price34.43

Change+1.50%

Gap+1.12%

Rel volume4.30×

Avg volume231.52K

Avg $ vol6.92M

SMA 2029.38

SMA 5029.18

SMA 200—

Price vs 50+18.00%

Price vs 200—

MA stack—

50/200 cross—

Supertrendup · 27.89

RSI (14)68

MACD hist0.70

MACD crossbull · 7d

Stoch %K / %D95 / 94

ADX (14)17

+DI / −DI26 / 10

RSI divergence—

MACD divergence—

ATR %+6.00%

ADR %6.88%

52w high34.43

52w low25.68

From 52w high+0.00%

Above 52w low+34.07%

New 52w highYes

SqueezeOff

Bollinger width30.06%

%B1.07

Donchian pos96.36%

Donchian high34.79

Donchian low24.90

AVWAP (52w high)34.04

vs AVWAP high+1.16%

AVWAP (52w low)29.74

vs AVWAP low+15.78%

OBV trendUp

Chaikin MF (20)0.24

Today vs 20d4.30×

Avg vol (14d)216.96K

Avg vol (20d)231.52K

Avg $ vol (20d)6.92M

Market cap—

RS 3m (vs SPY)+20.26%

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank92.5

1 week+20.81%

1 month+22.70%

3 months+25.98%

6 months—

1 year—

YTD+16.75%

P/E—

P/B-5.69

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq-0.06

Current11.03

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target52.00

Target upside53.35%

Analyst ratingBuy

Institutional6.69%

Ent. value1.43B

Revenue—

Net income-26.87M

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out44.33M

Employees—

ListedThu, Apr 30, 2026

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA+

Conviction100 / 100

Pattern quality—

Tech rank92.5 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance33.28

Support25.86

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in AVLN

All disclosures →

No recent disclosed trades by Congress in AVLN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AVLN · 4 buys · 6 sells

Insider	Side	Shares	Value	Traded	Filed
Novo Holdings A/S 10% owner · Series D Preferred Stock · 2026-05-01	Convert	12.56M	$0	2026-05-01	2026-05-05
FMR LLC 10% owner · Common Stock · 2026-05-01	Convert	80.29K	—	2026-05-01	2026-05-05
FMR LLC 10% owner · Common Stock · 2026-05-01	Convert	727.59K	—	2026-05-01	2026-05-05
Novo Holdings A/S 10% owner · Voting Common Stock · 2026-05-01	Buy	555.55K	$10.0M	2026-05-01	2026-05-05
FMR LLC 10% owner · Series A Preferred Stock · 2026-05-01	Convert	727.59K	—	2026-05-01	2026-05-05
FMR LLC 10% owner · Series D Preferred Stock · 2026-05-01	Convert	377.95K	—	2026-05-01	2026-05-05
FMR LLC 10% owner · Series B Preferred Stock · 2026-05-01	Convert	80.29K	—	2026-05-01	2026-05-05
FMR LLC 10% owner · Common Stock · 2026-05-01	Convert	225.84K	—	2026-05-01	2026-05-05
FMR LLC 10% owner · Series C-2 Preferred Stock · 2026-05-01	Convert	225.84K	—	2026-05-01	2026-05-05
Novo Holdings A/S 10% owner · Series B Preferred Stock · 2026-05-01	Convert	1.99M	$0	2026-05-01	2026-05-05

SEC filings

EDGAR filings in AVLN · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.